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Abstract
Adult obesity has become a significant problem in the United States. To reduce health
consequences and the rising cost of obesity, evidence-based guidelines to identify and treat
obesity are available to primary care providers (PCPs). Despite literature supporting favorable
outcomes by PCPs who address obesity at a patient's visit, studies indicate obesity counseling is
occurring infrequently, particularly in military primary care settings.
Guided by the Diffusion of Innovations Theory, this research utilization project evaluated
whether there is an implementation gap between use of the Department of Veterans Affairs (VA)
and Department of Defense (DoD) Clinical Practice Guideline for Screening and Management of
Overweight and Obesity and military primary care providers’ provision of care for adult obese
individuals. A retrospective review of electronic medical records was conducted at an Air Force
military treatment facility and continued until 50 records were identified that met inclusion
criteria (i.e., TRICARE beneficiaries age 19 and older with a body mass index (BMI) of 30
kg/m2 or greater).
The rate of identification of adult obesity was 36%. Only 36% of individuals were
offered diet and exercise counsel. Sixteen percent were offered behavioral counsel and 12%
received a one-month follow-up appointment. No individuals eligible to receive pharmacologic
and bariatric surgical treatment were offered these interventions. The overall composite score
for obesity treatment was 0.22, indicating identification and treatment of obesity occurred an
average of 22% of the time. Results of this research utilization project are consistent with other
studies, suggesting the need to determine barriers and implement interventions that can assist PCPs
in translating evidence to practice to reduce rates of adult obesity in the primary care setting.
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Chapter I
Introduction
Clinically, body weight status (i.e., underweight, overweight, obesity) is characterized by
the BMI—the ratio of an individual’s weight (in kilograms) to the square of the individual’s height
(in meters). For adults, obesity is defined in terms of a BMI equal to or greater than 30 kg/m2
(Centers for Disease Control and Prevention [CDC], 2012a). Since the 1990s, when the prevalence
of adult obesity in the United States (U.S.) averaged 10%–14%, this rate more than tripled
(Behavioral Risk Factor Surveillance System [BRFSS], 1990). In 1998, the prevalence was 15%–
19%; by 2007, 20%–24%; and by 2013, 25%–35% (BRFSS, 2013). A study of a military adult
active (AD) population found that from 2009 to 2012 the prevalence of obesity was 30.5%, which
was lower than the general population; however, for the non-active duty population, a prevalence
of 35.1% was comparable to the general population (Eilerman et al., 2014). Today, the prevalence
of obesity in the U.S. is over 36%, while the obesity rate for adults age 40–59 is as high as 40.2%
(Ogden, Carroll, Fryar, & Flegal, 2015).
Causes of Obesity
There are many factors influencing obesity, including physiological, psychological,
sociological, and environmental associations. In a study conducted by Owen-Smith, Donovan, and
Coast (2014), morbidly obese individuals reported several reasons for weight gain. The
researchers grouped these into four broad categories: (a) personal responsibility and “morality” of
health (e.g., individual’s attitude that mitigates personal accountability); (b) role of family structure
and importance of gender; (c) role of emotional distress and its impact on the body; and (d) the
vicious cycle and downward spirals that compound health conditions. Respondents felt there were
numerous psychosocial patterns, family history, and genetics that contributed to obesity.

1

Individuals reported that increased weight adversely affected physical and social aspects of daily
living that led to despair. Study participants felt it was a “vicious circle” (p. 1217) that was
difficult to stop.
Physiological factors. Physiologically, obesity results from overnutrition. An imbalance
between caloric intake and energy expenditure leads to increased adipose tissue storage (Skolnik &
Ryan, 2014). Adipose tissue and stomach regulators release chemical messengers that stimulate
the brain, creating an intricate balance between starvation and satiety that regulates body weight
(Chugh & Sharma, 2012; Skolnik & Ryan, 2014). When regulation becomes imbalanced, adipose
tissue secretes harmful inflammatory markers that lead to metabolic dysfunction of glucose and
cholesterol (Tchernof & Després, 2013). Research also indicates that through epigenetic
mechanisms, maternal dietary patterns increase the susceptibility to obesity that affect offspring by
inducing alterations through genetic expression (Martinez, Milagro, Claycombe, & Schalinske,
2014).
Psychological, sociological, and environmental factors. A range of diverse psychosocial
and environmental factors increase the risk of obesity. Childhood socialization patterns and family
roles, work patterns, and diet failures contribute to obesity (Owen-Smith et al., 2014). Insufficient
sleep patterns (Chaput, 2014) and emotional stress can potentiate the effects of obesity (Chao,
Grilo, White, & Sinha, 2015; Turk et al., 2012). Individuals report that weight adversely affects
relationships and contributes to fear of discrimination, low self-esteem, and self-loathing (OwenSmith et al., 2014). Business and manufacturing have also impacted obesity rates. Portion sizes
served in U.S. restaurants have increased two to three times over the past two decades (National
Heart, Lung, and Blood Institute, 2013). Karnani, McFerran, and Mukhopadhyay (2014) coined
the term "leanwashing" (p. 5) to describe how the food industry deceives the public into believing
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that the industry is helping to find ways to fight obesity—when, in fact, this industry contributes to
the prevalence of obesity in the general population through marketing of unhealthy processed
foods.
Consequences of Obesity
The body's inflammatory response to obesity contributes to several comorbid conditions.
Heart disease, stroke, type 2 diabetes (T2DM), hypertension (HTN), dyslipidemia, metabolic
syndrome, and obstructive sleep apnea (OSA) have been associated with obesity (Cawley &
Meyerhoefer, 2012; Ding et al., 2015; Drager, Togeiro, Polotsky, & Lorenzi-Filho, 2013; OwenSmith et al., 2014). Obesity also contributes to osteoarthritis and some types of cancer (Arnold et
al., 2016; Hootman, Helmick, & Hannan, 2011, April 29).
Estimates of obesity-related health care costs vary significantly. For example, An (2015)
estimated the health care cost of an individual with obesity in the U.S. is $1,809 higher than nonobese individuals; in contrast, Cawley and Meyerhoefer (2012) estimate the cost to be $2,741. A
2012 estimate of obesity related costs was $147 billion (CDC, 2015). The military health system
spends more than $1.1 billion annually on individuals with overweight and obesity-related
conditions, losing an estimated $1.1 million annually due to absenteeism and an additional $2.6
million annually due to presenteeism, where workers are less productive on the job due to health
issues (Hruby et al., 2015). A cost of more than $1 billion annually is reported by the Department
of Veterans Affairs (VA) for obesity-related issues (Tanofsky-Kraff et al., 2013).
Hruby et al. (2015) evaluated trends for individuals entering the Army. Administrative
costs increase for recruits who cannot meet physical stature and fitness requirements, resulting in
premature separation of the individual from service. It is estimated 27% of potential recruits (9
million young adults) are not eligible to enlist for military service because they do not meet weight

3

standards (Tanofsky-Kraff et al., 2013). This negatively influences military readiness and national
security.
Benefits of Weight Loss
Weight loss has clear benefits. With each kilogram of weight gained, the risk of T2DM
increases 4.5% to 9% across one to two decades (Rueda-Clausen, Ogunleye, & Sharma, 2015).
Mitigation of risk for T2DM occurs with as little as 5% to 10% weight loss, which is shown to
improve blood pressure, cholesterol, and glucose levels (Kushner & Sur, 2014). Weight loss has
also been associated with reduced osteoarthritis, reduced urinary and fecal incontinence, and, in
women, reduction in the severity of polycystic ovarian syndrome that can reduce the risk of
infertility (Rueda-Clausen et al., 2015).
Given the negative influence that obesity has on health and quality of life, several obesity
guidelines recommend comprehensive, high-intensive, multicomponent lifestyle interventions to
reduce obesity and its consequences (VA/Department of Defense [DoD], 2014; Jensen et al., 2013;
Moyer, 2012). In 2010, the U.S. Department of Health and Human Services (USDHHS)
established Healthy People 2020 goals for healthy eating and maintaining a normal weight
(USDHHS, 2010), and in 2011 the Centers for Medicare & Medicaid Services (CMS) approved up
to 14 visits over 6 months for obesity counseling (CMS, 2011), in an effort to minimize obesity's
negative consequences.
Problem Statement
Although clinical guidelines for the management of obesity in the primary care setting
exist, obesity rates continue to rise. Studies show counseling by PCPs at a clinic visit reduces
the rate of obesity (Kanaya, 2012; Sprau, Tindall, Lovegrove, Watowicz, & Eneli, 2015;
Wadden, Butryn, Hong, & Tsai, 2014). Kraschnewski et al. (2013) reported that there has been a
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decline in weight-related counseling in the primary care setting. Rates evaluated from 1995 to
1996 and 2007 to 2008 found a decrease in counseling rates from 7.8% to 6.2%. A survey of 1,740
PCPs regarding weight screening and treatment practices noted greater than 80% of PCPs had
available diet, exercise, and weight control resources; however, only 45% billed for counseling or
treatment services and just 26% reported on obesity assessment or routine counseling and tracking
of weight control progress (Klabunde et al., 2014). In a systematic review of 12 clinical trials
conducted from 2005 to 2013, no studies utilized the recommended comprehensive lifestyle
interventions of 14 sessions over a six-month timeframe (Wadden et al., 2014).
Lack of knowledge or disagreement with the guidelines, attitude or self-efficacy,
anticipated outcomes, apathy, and external barriers were cited as reasons PCPs do not initiate
obesity counseling (Sadeghi-Bazargani, Tabrizi, & Azami-Aghdash, 2014). Other barriers that
persist are lack of time and consistency in care, individual receptivity, compliance with change,
and lack of organizational support or constraints (Abruzzino & Marra, 2015; Monsen et al.,
2014; Sadeghi-Bazargani et al., 2014; Sinfield, Baker, Pollard, & Tang, 2013). Collectively,
these barriers contribute to an underutilized resource for the identification and treatment of
obesity in the primary care setting.
Purpose Statement
The PCP plays a crucial role in reducing the rate of obesity for adults in primary care.
Evidence-based recommendations are available to guide PCPs in the management of adult
obesity. The purpose of this project is to examine electronic medical records (EMRs) of adults
who meet criteria for obesity and compare documented treatment with treatment recommended
according to the evidence-based VA/DoD obesity screening and management guideline.
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Chapter 2
Literature Review
The purpose of this literature review is to define adult obesity and to compare and
contrast current evidence-based obesity guidelines. This review will explore current practices
for the identification and treatment of obesity by PCPs. Additionally, this review will investigate
gaps and interventions available to improve translating evidence-based guidance into primary
care settings.
Key terms and phrases used for the literature search were: obesity, adult obesity,
definition of obesity, impact of obesity, primary care and obesity, management of obesity in
primary care, obesity clinical practice guidelines, obesity treatment, evidence-based practice
(EBP), barriers to use of clinical practice guidelines, interventions and clinical practice
guidelines, and Diffusion of Innovations Theory. Databases searched were Annual Reviews,
Business Source Complete, Cochrane Reviews, CINAHL, PsychInfo, PubMed, and
ScienceDirect. Articles published in English and from the year 2011 were included. Articles
dated earlier than 2011 were included only if they contained relevant historical information that
support this research utilization project.
Defining Adult Obesity
Obesity has been present throughout history, uncovered even in artifacts dating back to
the Stone Age. Through ancient times, obesity occurred in the higher class in Egypt. The first
literature written about obesity appeared in the 18th century when Adolphe Quételet, a Belgium
astronomer and mathematician, devised an equation to measure a person’s height relative to their
body weight called the Quételet Index, better known as the BMI (Williams & Frühbeck, 2009).
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Medically defined, adult obesity is the accumulation of excess body fat in individuals
aged 20 years and older (CDC, 2012b). However, quantifying obesity has been more
challenging. The first measurements were established by the Metropolitan Life Insurance
Company, which developed actuarial tables based on gender and weight-for-height using data
from the Build and Blood Pressure Study published in 1959 (Simopoulos, 1986).
By the 1960s, a national survey utilized height and weight measurements of examined
and non-examined individuals (USDHHS, 1974). This later became the National Health and
Nutrition Exam Survey in the 1970s after a dietary component was included in the survey (CDC,
2014). Currently, BMI is used nationally and internationally to define obesity (CDC, 2016;
World Health Organization [WHO], 2016). Obesity is categorized as Grade I obesity with a
BMI >30 – 34.9 kg/m2, Grade II obesity with a BMI >35 – 39.9 kg/m2, and Grade III obesity,
also known as morbid obesity, with a BMI >40 kg/m2.
Other common anthropometric measures used to quantify obesity are waist circumference
(WC), waist-to-hip ratio (WHR), waist-to-stature ratio (WSR), and percentage of body fat
(Rueda-Clausen et al., 2015). The military takes measurements of the neck and abdomen to
calculate percent of body fat for individuals who fail the weight or abdominal circumference
portion of the physical fitness test (Secretary of the Air Force [AF], 2015). Mohammadifared et
al. (2013) found that although BMI is a better predictor of T2DM, HTN, and dysplipidemia in
men, WC is a better indicator of diabetes and hypertension in women. In an Expert Consultation
Report, the WHO recommends use of either WC or WHR in conjunction with BMI (WHO,
2008), as these measures are viewed as more accurate indicators of cardiovascular (CV) disease
risk (Nazare et al., 2015; Xu et al., 2015).
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Newer technologies available to measure body fat are magnetic resonance imaging
(MRI), computed tomography (CT), ultrasonography, and bone densitometry (DEXA), as well as
air displacement plethysmography, known as the BodPod, and hydrodensitometry, which is a
water weighing technique (Müller et al., 2013; Rueda-Clausen et al., 2015). These technologies
are accurate but incur greater cost and time to obtain measurements, while the bioelectrical
impedance can result in fluctuations due to hydration status (Rueda-Clausen et al., 2015). See
Appendix A for advantages and disadvantages of current methods to measure obesity.
Some disadvantages when using BMI relate to an over or underestimate of body fat
percentage (De Schutter, Lavie, Arce, Menendez, & Milani, 2013). Further, BMI does not
discern between lean versus fat mass, resulting in inaccurate body fat analysis (Lambert et al.,
2012). In non-Europeans, particularly Asians, CV risk is higher despite a normal BMI.
Consideration to lower the BMI threshold to diagnose obesity at >25 kg/m2 has been
recommended for this population (WHO, 2000). Despite these known limitations, BMI remains
a widely accepted anthropometric measure for its ease of use and cost-effectiveness in the
primary care setting. Until an uncomplicated technology becomes available, use of BMI remains
a key clinical tool to assess obesity.
Recommended Adult Obesity Guidelines
Four current obesity guidelines for clinical practice are available. These include: (a) the
2015 Endocrine Society guideline for the pharmacological management of obesity (Apovian et al.,
2015); (b) the 2014 VA/DoD guideline to screen and manage adult overweight and obese
individuals; (c) the 2013 American Heart Association (AHA) Task Force, American College of
Cardiology (ACC), and The Obesity Society (TOS) guideline for adult overweight and obesity
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management (Jensen et al., 2013); and (d) the 2012 United States Preventive Task Force (USPTF)
recommendation statement on the screening and management of adult obesity (Moyer, 2012).
The Appraisal of Guidelines for Research and Evaluation II (AGREE II) Instrument is a
23-item survey to assess quality, methodological strategy, and nature of the information reported in
the guidelines (Brouwers et al., 2010). The six domains for guideline evaluation are: (a) scope and
purpose; (b) stakeholder involvement; (c) rigor of development; (d) clarity of presentation; (e)
applicability; and (f) editorial independence. Evaluation results are available in Appendix B.
Both VA/DoD (2014) and AHA/ACC/TOS (Jensen et al., 2013) guidelines scored high in
scope and purpose, rigor of development, and clarity of presentation domains. However, the
VA/DoD (2014) guideline provided the most comprehensive recommendations. Treatment
recommendations from VA/DoD include diet, exercise, behavioral modification, and adjunct
therapies for pharmacological and surgical intervention. The AHA/ACC/TOS guideline does not
include pharmacologic therapy, but when coupled with the Endocrine Society's
recommendations (Apovian et al., 2015), the AHA/ACC/TOS guideline is equally
comprehensive as the VA/DoD guidance. Recommendations in the USPTF guideline (Moyer,
2012) mirror VA/DoD and AHA/ACC/TOS on use of comprehensive lifestyle intervention
(CLI). No guidelines addressed individual or public involvement, although the VA/DoD and
Endocrine Society recommend use of shared decision-making when treating individuals with
obesity. See Appendix C for an overview of the obesity guidelines.
Identification of Adult Obesity in Primary Care
Obesity is identified in the presence of a BMI >30 kg/m2. Both VA/DoD (2014) and
AHA/ACC/TOS (Jensen et al., 2013) guidelines recommend initiation of CLI and offering
pharmacologic intervention for a BMI >27 kg/m2 if an individual has comorbid conditions. The
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guideline by AHA/ACC/TOS advocates for use of WC as an additional assessment tool, though
there is no cut-point recommendation for this measure. Skolnik and Ryan (2014) report that a
WC greater than 40 inches for males and greater than 35 inches for females has been associated
with increased risk of CV disease.
McKinney (2013) discusses metabolic syndrome as a comorbid condition even when an
individual does not meet BMI criteria for obesity. Identification of this syndrome can inform the
PCP to intervene at earlier stages to reduce future CV risk. In addition to a WC cut-point of
greater than 40 inches in males and greater than 35 inches in females, other indicators are as
follows: (a) a triglyceride level above 150 mg/dl; (b) a high density lipoprotein cholesterol level
less than 40 in males and less than 50 in females; (c) an elevated blood pressure above 130/85 or
receiving treatment for HTN; and (d) an elevated fasting glucose above 100 or being treated for
elevated glucose. Meeting three of the five criteria is diagnostic of metabolic syndrome.
Treatment of Adult Obesity in Primary Care
The AHA/ACC/TOS (Jensen et al., 2013), VA/DoD (2014), and USPTF (Moyer, 2012)
guidelines recommend lifestyle interventions for the treatment of obesity. Both AHA/ACC/TOS
and VA/DoD guidelines describe this as comprehensive, while USPTF describes the intervention
as intensive and multicomponent. Modalities under lifestyle interventions are
nonpharmacologic, including diet, exercise, and behavioral counseling. Variations among the
guideline treatment recommendations exist; some initiate interventions at different cut-points and
some interventions vary in degree of intensity.
The Endocrine Society supports the use of diet, exercise, and behavioral counseling but
does not use the terms comprehensive or multicomponent (Apovian et al., 2015). In the presence
of comorbid conditions, a cut-point BMI of >27 kg/m2 is used to establish when CLI and
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pharmacologic management should be started. A BMI of >40 kg/m2 or >35 kg/m2 with
comorbid conditions is a cut-point for considering bariatric surgical intervention (Apovian et al.,
2015; Jensen et al., 2013; VA/DoD, 2014).
Dietary and physical activity. The importance of diet and physical activity is the
hallmark for obesity treatment. Prescribing a particular diet or exercise regimen can be
perplexing for the PCP due to limited time or level of expertise (Plourde & Prud'homme, 2012).
Fortunately, research indicates that diet is not dependent on a specific regimen to improve weight
loss outcomes or reduce CV risks. Rather, it is calorie restriction and adherence to the dietary
modification that equate to success (Johnston et al., 2014; Rees et al., 2013). This simple
recommendation makes it easier for a PCP to provide dietary counsel.
A diet and physical activity plan that decreases caloric intake by 500 to 1,000 kilocalories
(kcals)/day can reduce weight at a rate of one-half to two pounds weekly. This diet and exercise
intervention can result “in a 5-10% reduction in body weight over [six] months” (VA/DoD,
2014, p. 29). The AHA/ACC/TOS guideline recommends a caloric deficit of 500 to 750
kcals/day (Jensen et al., 2013). Very low calorie diets consist of a daily caloric intake of >450
kcals but <800 kcals (Mullins, Hallam, & Broom, 2011). The VA/DoD (2014) guidance
recommends offering this option only for 12 to 16 weeks under medical supervision. The
AHA/ACC/TOS (Jensen et al., 2013) guideline did not find adequate evidence to recommend
this as a dietary treatment. Other dietary cautions are to avoid reduced caloric intake for
individuals who are pregnant or lactating or who have a history of anorexia nervosa, bulimia, or
unstable illness such as cancer or recent CV events (Kushner & Sur, 2014).
The American College of Sports Medicine (ACSM) recommends 150 to 250 minutes of
physical activity weekly to assist in weight loss (ACSM, 2011). Interestingly, physical activity
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alone has not resulted in significant weight loss (Kushner & Sur, 2014; Plourde & Prud’homme,
2012; Thomas, Kyle, & Stanford, 2015). Weight loss through exercise requires very high
intensity activity. As the body loses weight, the amount of energy expended decreases. At a
10% loss in body weight, there will be a 15% reduction in energy expenditure (McKinney,
2013). Therefore, the additive effect of energy expenditure through exercise improves
continuation of weight loss (VA/DoD, 2014).
Notably, physical activity plays a larger role in maintaining weight and improving CV
risks. In a study conducted by Dankel, Loenneke, and Loprinzi (2015), independent of
overweight or obesity status, a decrease in activity increased the risk of all-cause mortality.
Vigorous activity demonstrates a greater effect upon decreasing respiratory and CV disease risk.
Any exercise that promotes muscle strength and flexibility enhances bone density and joint
flexibility (ACSM, 2011).
Intensive behavioral counsel. Combining diet and physical activity with behavioral
modification strengthens both weight loss and weight maintenance for adults with obesity
(Roqué i Figuls et al., 2013). The frequency for intensive behavioral treatment of obesity, as
established by CMS (2011), equates to one face-to-face visit weekly for the first month, then
every other week for the next five months. During months 7 through 12, visits are to be face-toface monthly, totaling 20 visits per year. This closely mirrors USPTF’s recommendation
(Moyer, 2012) for 12 to 26 sessions per year. VA/DoD (2014) recommends 12 visits yearly,
while AHA/ACC/TOS recommends a high-intensity frequency of >14 sessions within six
months (Jensen et al., 2013).
Although session frequency varies, the Diabetes Prevention Program found progression
to diabetes was reduced 60% when using intensive behavioral intervention, versus a 31%
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reduction with usual care (McKinney, 2013; Sussman, Kent, Nelson, & Hayward, 2015). During
the Look AHEAD trial, which stands for Action for Health in Diabetes, participants experienced
a statistically significant amount of weight loss for individuals with Grade III obesity receiving
intensive therapy, more than individuals with Grade I and II obesity receiving a less intensive
therapy (Unick et al., 2011). Further, telephone-delivered counsel is a convenient and costeffective approach to the delivery of behavioral services (Wadden et al., 2014). Utilizing a
commercial provider such as Weight Watchers was as cost-effective as standard care, leading to
an average weight reduction of 4.8 – 6.6 kg across six months (Fuller et al., 2013; Jensen et al.,
2013).
The importance of other behavioral strategies can increase an individual’s success with
weight loss and management. Assessing readiness, removing barriers to assist in reaching
realistic goals, and self-monitoring are a part of intensive treatment regimens that result in
greater weight loss (Jensen et al., 2013; Moyer, 2012). To assist individuals who are ambivalent
about changing behaviors, use of motivational interviewing can improve weight loss efforts
(Pearson, Irwin, Morrow, Battram, & Melling, 2013; VA/DoD, 2014). The 5As developed by
the CMS provides counseling in a stepwise approach to help individuals make behavioral
changes. The 5As address assessment and advice of the individual, agreeing to reach goals
through shared decision-making, assisting in the individual's self-monitoring and goals, and
arranging follow-up and referrals for obesity treatment (McKinney, 2013; Vallis, PiccininiVallis, Sharma, & Freedhoff, 2013).
Pharmacologic and surgical intervention. Adjunctive obesity therapies include
pharmacological and surgical options. Pharmacotherapy is considered when nonpharmacologic
interventions have not improved weight loss and when an individual’s BMI is >30 kg/m2 or >27
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kg/m2 associated with comorbid conditions (Apovian et al., 2015; Jensen et al., 2013; VA/DoD,
2014). A meta-analysis by Johansson, Neovius, and Hemmingsson (2014) demonstrated
pharmacologic therapy also enhances weight loss maintenance. The VA/DoD currently
recommends individuals continue on weight loss medication after reaching their weight loss goal
to assist with weight maintenance (VA/DoD, 2014).
Medications available for long-term use are orlistat, phentermine, lorcaserin, liraglutide,
or combinations of either naltrexone with bupropion or phentermine with topiramate (Apovian et
al., 2015). Appendix D outlines these agents, their activity, recommended dosages, and risks and
benefits. When selecting medication therapies for obese individuals with comorbid conditions,
the Endocrine Society also recommends to choose options that have the least weight gain side
effect and to exercise caution when prescribing stimulants for individuals with a CV history
(Apovian et al., 2015). Johansson et al. (2014) did not find benefit for use of nutritional
supplements. It is necessary for PCPs to have a baseline knowledge of benefits, risks, and
alternatives to nutritional supplements to provide effective obesity counsel.
Bariatric surgery has shown to be an effective option for obesity treatment.
Consideration is made for individuals with a BMI >40 kg/m2 or those with a BMI >35
kg/m2 who have comorbidities (Apovian et al., 2015; Jensen et al., 2013; VA/DoD, 2014).
Although USPTF did not review surgical intervention as an obesity treatment, guideline
recommendations did support this option (Moyer, 2012). The most common procedures are
Roux-en-Y gastric bypass, laparoscopic band, and the gastric sleeve (VA/DoD, 2014).
Depending on the procedure, a 20% to 35% sustained weight loss across two to three years’ postsurgery is reported (Ryan, 2014). Additionally, there is greater reduction of T2DM and
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metabolic syndrome, and improved quality of life, than with nonsurgical interventions alone
(McKinney, 2013; Ryan, 2014).
Surgical intervention can increase weight loss; however, the individual must understand
there are inherent risks with this option. The occurrence of surgical complications, along with
ulceration, malabsorption of micronutrients following gastric bypass, treatment failure, and
adverse psychological events have been reported (McKinney, 2013; Jensen et al., 2013; Ryan,
2014; VA/DoD, 2014). It is important for PCPs to understand the risks and benefits of surgical
treatment, as well as the management of surgical candidates post-operatively. Guidelines for
post-operative care through The Obesity Society, the American Society for Metabolic &
Bariatric Surgery, and the American Association of Clinical Endocrinologists are available to
assist PCPs (Ryan, 2014).
Needs Assessment
The prevalence rate of obesity in the AD population is slightly below the civilian
community, while the non-AD military population is comparable to the civilian sector (Eilerman
et al., 2014). Even though evidence-based guidelines exist and it is known that weight loss
endeavors are more likely to occur when PCPs engage individuals on obesity (Dutton et al.,
2014), the literature indicates this has declined 12% from 2008 to 2013 (Fitzpatrick & Stevens,
2017). With rising health care costs from comorbidities associated with obesity, it is critical for
military PCPs to address this issue at clinic visits.
Population identification. Eilerman et al. (2014) indicates the AD military's prevalence
rate of obesity was 30.5% from 2009 to 2012. Smith et al. (2012) found that while overweight
rates for AD declined from 2002 to 2005, obesity rates rose significantly. Where 40% of the AD
military population report a healthy weight, only 33% of military dependents are at a healthy
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weight (Eilerman et al., 2014). For purposes of this research utilization project, TRICARE
beneficiaries 19 years of age and older (i.e., AD, AD dependent, retirees, retiree dependents, and
TRICARE-for-Life) will be included.
Identification of the project sponsor/key stakeholders. Evaluation will be conducted at
a military treatment facility (MTF) located in Maryland. Key stakeholders include the
organization's executive leadership, the AF Diabetes and Obesity Research Working Group,
Population Health Working Group, PCPs, nursing and technician staff, nutritional and behavioral
medicine, and TRICARE beneficiaries. External stakeholders are United Health Care and the
VA/DoD.
Organizational assessment/assessment of available resources. The MTFs provide
primary care services for TRICARE beneficiaries. The current model of care is the AF Medical
Home model. The medical home is comprised of a grouping of individual provider teams, which
include one physician and either a physician assistant (PA) or nurse practitioner (NP), or a
combination of the two. Enrollment for each PCP in the Family Practice Clinic is 1,250
TRICARE beneficiaries.
The PCPs utilize an EMR, which automatically calculates BMI. Clinic visits are 15 to 20
minutes in length. A PCP’s support team is comprised of administrative, nursing, and medical
technician staff. Internal referral services are available for nutritional and behavioral medicine
services. These services are offered dependent on availability of nutritional and behavioral
medicine staff. No exercise physiologist is available, but all TRICARE beneficiaries possess a
military identification card that affords access to the base fitness center. Physical therapy
services are available, but access is limited for exercise management. Although PCPs may
prescribe pharmacologic options, this option is not a covered benefit under TRICARE
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(TRICARE, 2016). A nonformulary request can be placed by the PCP to assist individuals with
coverage of their pharmacologic treatment but is dependent on pharmacy approval. Bariatric
surgical options are covered for individuals whose BMI is > 35 kg/m2 with comorbid conditions
or whose BMI is > 40 kg/m2. Dietary services and exercise physiology referrals outside the
facility are not a routine, covered TRICARE benefit.
Team selection and formation. The committee is comprised of a Committee Chair, an
expert committee member on the topic, and an outside neutral committee member from the
University of Nevada Las Vegas (UNLV). Consultation and coordination is accomplished as
needed with the AF Research Oversight and Compliance Division and the representative of the
MTF’s Clinical Research Office and Health Insurance Portability and Accountability Act
(HIPAA) to assist in processing the project’s approval at the MTF level. Assistance from
Information Systems, Population Health/Disease Management, Family Practice Clinic
leadership, and nutritional and behavioral medicine representatives is available as needed.
Cost – benefit analysis. This research utilization project will be part of a larger longterm project to generate a reduction in obesity rates. Future interventions will be evaluated if
findings from this project indicate a gap in the implementation of evidence-based guidelines for the
identification and treatment of adult obesity. Considerations for future cost-benefit analyses
include reduction in therapies for individuals diagnosed with comorbid diseases associated with
obesity. Additionally, reduced number of prescriptions required to manage chronic disease, a
reduction in specialty services, or reducing person-hours required to manage chronic disease in the
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MTF may be considered. No cost-analysis will be conducted for this research utilization project
due to the purpose and length of the project.
Scope of the project. The scope of this project is to determine if there is an
implementation gap between documented identification and treatment and recommended
identification and treatment of obesity according to the evidence-based VA/DoD obesity screening
and management guideline.
Mission/Goals/Objectives
Mission. The mission of this research utilization project is to reduce the paucity of
literature related to adult obesity identification and treatment in the military population and to
identify if a gap exists between actual and recommended identification and treatment of adult
obesity in accordance with the VA/DoD evidence-based screening and management guideline.
Goals. One goal for this research utilization project is to evaluate if military PCPs
identify and treat obesity in adults in the primary care setting according to the VA/DoD adult
obesity guideline. Additionally, it is anticipated this project will help to reduce gaps in the
literature related to military PCPs and the identification and treatment of adult obesity in
accordance with the VA/DoD adult obesity guideline.
Objectives. To meet the goal of this project, a retrospective chart audit was conducted to
establish a baseline for military PCPs’ identification and treatment of obesity in adults in the
primary care setting according to the VA/DoD adult obesity guideline. The chart audit began
after project approval was granted by the UNLV Biomedical Sciences Institutional Review
Board (IRB) and the AF Research Oversight and Compliance Division approval. See Appendix
E for research utilization project timelines and Appendix F for approval letters.
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Chapter 3
Theoretical Underpinnings
Introduction
One approach to solving clinical problems is the use of evidence-based practice (EBP),
which incorporates the best research evidence available with integration of clinical expertise and
individual preference (Ahmed, Andrist, Davis, & Fuller, 2013; Polit & Beck, 2017). Sources
that yield the best evidence are meta-analyses, systematic reviews, and clinical guidelines based
on randomized controlled research (Zaccagnini & White, 2014). Other sources of evidence
come from well-designed quasi-experimental and descriptive research (Dearholt & Dang, 2012).
Where EBP is used to “inform clinical, administrative, and educational” practice (Dearholt &
Dang, 2012, p. 4), research utilization allows research study findings to be translated or applied
in response to clinical issues (Ahmed et al., 2013; Polit & Beck, 2017).
Several models guide translation of research knowledge into practice. One such model is
the diffusion of innovations theory, developed by Everett Rogers in 1962 (Rogers, 2003). This
theory focuses on the process whereby an innovation is accepted and integrated as a part of or as
a whole of the original research. It also allows adaptation when implementing evidence to
address local needs and resources (Polit & Beck, 2017). Rogers’ theory describes the process by
which an innovation becomes the fabric of a social system and provides ways to bridge gaps
between research and utilization (Dingfelder & Mandell, 2011).
Diffusion of Innovations Theory
There are four major elements described in the diffusion of innovations theory: (a)
innovation; (b) communication channel; (c) time; and (d) the social system (Rogers, 2003). The
innovation can be a product, practice, program, policy, or service introduced to individuals or
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groups. It is not a prerequisite for the innovation to be new; rather, the innovation should
improve quality for those who adopt the innovation (Leggott et al., 2016). The innovation must
demonstrate advantage(s) over other options, be compatible with the values of the users, be
trialed and easy to use, and have adequate visibility of its success to smooth the path to adoption
(Rosen & Goodson, 2014). Communication is the second element of the theory, which occurs
when individuals or groups receive information about the innovation (Rogers, 2003). An
important principle of this element is that individuals or groups have access to this information
and that the communication is two-way (Kim, Quinn, Chandrasekar, Patel, & Lam, 2016).
The third element is time, which considers the length of exposure required for individuals
or groups to adopt or reject the innovation. Rogers (2003) enumerates the steps in the
innovation-decision process to adopt an innovation as: (a) knowledge; (b) persuasion; (c)
decision; (d) implementation; and (e) confirmation. The speed by which the innovation is
adopted depends on attributes of the adopter. Innovators are the first adopters who embrace the
innovation. Early adopters accept the innovation sooner than the early majority, while the later
majority tends to be slower in innovation adoption. The laggards are the skeptics or critics of the
innovation (Rogers, 2003).
The fourth element of the diffusion of innovations theory is the social system. Within the
system are leaders that influence the adoption process. Opinion leaders help diffuse innovations
among individuals or groups through active and passive communication methods (Nejad,
Sherrell, & Babakus, 2014). Change agents garner support from opinion leaders to influence
adoption of the innovation. Innovation champions are charismatic and can overcome barriers to
boost innovation adoption (Rogers, 2003).
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Figure 1. Diffusion of Innovations Theory (adapted from Rogers, 2003).
Application of Diffusion of Innovations Theory
Many studies have examined various aspects of the four elements within the diffusion of
innovations theory. Some studies serve to explore or explain attributes of the innovation,
communication methods, and rates of adoption. Other studies help to describe characteristics of
adopters, opinion leaders, change agents, or champions who influence the social system to better
explain how the process of diffusion and adoption of an innovation occurs. Collectively, these
studies help to understand the dynamic process by which an innovation is translated into
practice.
The current project examines the implementation gap between use of the VA/DoD
evidence-based guideline and PCPs’ provision of care for adult obese individuals. The VA/DoD
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guideline has been in existence since 2006, with the most recent update in 2014 (VA/DoD, 2014).
However, the literature suggests PCPs may not adhere to the established guideline. One factor that
influences adoption of the innovation is the concept of observability. One study using the diffusion
of innovations theory explored the adoption of EBP by nursing students in an international setting.
The researchers addressed components of the first element of the theory including advantage,
compatibility, complexity, trialability, and observability as they relate to adoption of the EBP
innovation. Components of Element 1 directly affect persuasion and adoption of EBP.
Additionally, knowledge of EBP was significantly related to adoption and implementation of the
innovation (Pashaeypoor, Ashktorab, Rassouli, & Alavi-Majd, 2016).
Although knowledge can impact adoption and implementation, a study by Nichol et al.
(2011) reinforced that knowledge alone is not the catalyst for change, but rather exposure to
ongoing communication within social systems is required to keep the innovation viable. Following
initiation of a glucose screening protocol, target glucose screenings for individuals with a
psychiatric diagnosis increased from 46% to 67% but remained below the targeted 70% threshold.
When the researchers increased reinforcement tools to include reminder notifications and
information published in a monthly newsletter, as well as provided reported screening rates to
individual providers during the second and third year, screenings increased to the 90% threshold.
Clinics that did not receive reinforcement tools averaged 26% to 38% lower on glucose screenings.
This theory has been used in the fields of business and technology, as well. The need to
understand the adoption and implementation of the Radio Frequency Identification (RFID)
technology was critical before marketing it to the public. A questionnaire tested concepts of the
adoption phase of the theory. The adoption steps of knowledge, design, decision, and
implementation were positively associated with adoption of RFID technology. Interestingly,
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persuasion had a negative influence. This demonstrates that uncertainty in adopting newer
technology can occur when the element of communication to convey innovation benefits is
suboptimal (Bhattacharya, 2015).
Leggott et al. (2016) used a mixed methods study to investigate the rate of diffusion of
innovation when adopting a new anesthetic procedure for surgery. Adopters in this study
perceived the new innovation to be safer, more efficient, and easier to use than the older
anesthetic technique. Because adopters felt this innovation was better than the previous
procedure, the year this technique became available there was more than a 15% adoption rate
that rose to 70% almost a decade later. Results of this study have been validated by other
research. When an innovation is perceived to be credible and adopters are trusting of its use, it is
much more likely to be implemented (Kim et al., 2016).
Characteristics of adopters, opinion leaders, change agents, and champions affect
diffusion of an innovation. In a survey of 88 nurses, Andrews, Tonkin, Lancastle, and Kirk
(2013) identified 18 adopter characteristics. Although not generalizable, some of the
characteristics noted are possessing greater knowledge and confidence to adopt the innovation
into practice. Level of competence and accessibility to the opinion leaders are critical for others
to adopt an innovation (Rosen & Goodson, 2014). Equally important is to identify positive as
well as negative influences that opinion leaders, change agents, and champions have about the
diffusion process (Nejad et al., 2014). Diffusion of innovations theory supports the need to
continue identifying and addressing variables that impact the diffusion process in order to
successfully implement and sustain an innovation (Dingfelder & Mandell, 2011).
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Theoretical Constructs
The theoretical constructs of the diffusion of innovations theory for this project will be as
follows. The innovation is operationalized as the VA/DoD obesity guideline. To determine if
PCPs are implementing the VA/DoD guideline, evaluation of the decision, implementation, and
confirmation to adopt the innovation will be operationalized as the identification of obesity,
defined as a BMI > 30 kg/m2, as well as use of treatment indicators. The treatment indicators are
operationalized as offering diet, exercise, behavioral modification, and pharmacological
treatment for individuals with a BMI > 30 kg/m2 and bariatric surgical intervention for
individuals with a BMI > 35 kg/m2 with comorbid conditions or a BMI > 40 kg/m2.

24

Chapter 4
Project Plan
Setting
This research utilization project was conducted at an AF MTF located in Maryland and
accomplished with retrospective chart review of EMRs. The documented treatment of adults
with obesity was compared to evidence-based treatment guidelines adopted by the VA/DoD for
screening and management of obesity (VA/DoD, 2014). The population of interest was adults
who receive care under the military health insurance known as TRICARE. Inclusion criteria for
this evaluation project were EMRs of adults, defined as age 19 years and older with a BMI > 30
kg/m2, the entry BMI for a diagnosis of obesity.
Protection of Human Subjects
Approval from the UNLV IRB was granted on 5 September 2016. A HIPAA waiver for
the retrospective review was requested and granted by the UNLV IRB on 24 October 2016.
Permission to access electronic health records, including the Armed Forces Health Longitudinal
Technology Application (AHLTA), Composite Health Care System (CHCS), and the CarePoint
database, was subsequently approved by the AF Research Oversight and Compliance Division
and the MTF’s HIPAA representative on 23 December 2016.
Per the AF Research Oversight and Compliance Division, collection of data could only
occur on records prior to the UNLV IRB approval date of 5 September 2016. Therefore,
retrospective review was on records between 1 April to 31 August 2016. Data collection began
after 1 January 2017. To ensure protection of any personally identifiable information, data was
de-identified, stored securely under password protection, and available only to the primary and
co-investigators.
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Data Sources, Sampling, and Data Collection
A retrospective examination of the MTF’s EMRs was conducted using AHLTA, CHCS,
and the CarePoint databases to identify adults defined as age 19 and older with obesity, defined
as a BMI of > 30 kg/m2, who are under the care of a PCP in the MTF’s Family Practice Clinic.
Review of EMRs continued until 50 records had been identified that met inclusion criteria for
this project. Use of the Obesity Treatment Audit Form (see Appendix G), based on the VA/DoD
obesity guideline, was used to examine the MTF’s EMRs to determine if treatment of obese
adults proceeded according to the evidence-based guideline recommendations. The Obesity
Treatment Audit Form did not contain any private or personal information that could link the
data collected on individuals or PCPs.
Each record audited was assigned a number (i.e., Record 1, Record 2, Record 3, etc.) to
ensure all information was de-identified when written on the Obesity Treatment Audit Form.
The record number on the audit form was not linked to the EMR. To provide additional
protection of confidentiality, electronic data collected is password protected and secured in a
locked facility at the MTF during data collection. Following completion of MTF data collection,
data will then be stored in a locked facility at UNLV for two years post completion of this
project. After the designated storage time, the electronic information gathered will be
electronically deleted and hard copy information will be shredded and recycled.
Measures
Seven treatment indicators on the Obesity Treatment Audit Form were collected: (a)
diagnosis of obesity if BMI > 30 kg/m2 ; (b) diet/nutritional counsel/consult offered; (c) exercise
counseling offered; (d) one-month follow-up appointment; (e) behavioral modification
counsel/consult offered; (f) pharmacologic intervention discussed for all eligible individuals with
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a BMI > 30 kg/m2, and (g) bariatric surgery option discussed for individuals with a BMI > 35
kg/m2 with comorbid conditions or a BMI > 40 kg/m2.
First, a yes or no was annotated for each indicator to evaluate actual treatment of obesity
according to the VA/DoD obesity guideline. These indicators were then tallied and a percentage
was scored as a calculation of the actual treatments received over total potential recommended
treatments, known as the Obesity Treatment Composite Score. This provided comparison
between actual treatment and treatment according to the guideline recommendations. For
instance, if an individual met four of the five potential indicators, the percentage would be
recorded as 0.80. If an individual met four out of seven potential indicators, the percentage
would be recorded as 0.57. Other variables such as age, gender, and beneficiary category were
recorded in the IBM® Statistical Package for the Social Sciences, Version 24 (SPSS® 24)
database, (IBM®, 2016).
Statistical Analyses
Analyses of the Obesity Treatment Audit Forms were conducted using SPSS® 24.
Descriptive data of age, gender, BMI, and beneficiary category were used. To identify if a gap
existed between actual treatment of obese adults and treatment according to VA/DoD guideline
recommendations, frequencies were run for each indicator, as well as a scored percentage of the
actual versus recommended indicators accomplished. A composite score could range from 0,
indicating absence of guideline adherence, to 1.0, indicating full guideline adherence.
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Chapter 5
Summary
Implementation
Data collection took place over two days and was accomplished by the co-investigator.
Records were selected from 1 April to 31 August 2016. Using the EMR known as AHLTA,
records were queried, sorting by the Family Practice PCP’s name and the inclusive dates to be
reviewed. Records were selected randomly; however, to avoid all data being collected from one
month, 10 records were selected throughout each of the five-month data collection timeframe.
Records were selected from the pool of all PCPs available during the data collection period to
avoid evaluating records from only one or two PCPs in the Family Practice Clinic. In order to
ensure records evaluated met eligibility criteria, records were selected on individuals 19 years of
age or older. The BMI was only identified once the record was opened to review the note.
Therefore, a total of 119 records were reviewed in order to obtain 50 records meeting BMI
criteria of 30 kg/m2 or greater. Information was gathered using the Obesity Treatment Audit
Form. Additional variables of age, gender, beneficiary category, PCP credential type (i.e.,
physician, PA/NP), and reason for visit were collected and entered in a SPSS® 24 database for
data analysis.
Results
Individual visits. Of the 50 records studied, 54% (n=27) were male and 46% (n=23)
were female. Age of individuals ranged from 21 to 68 years, with an average age of 50 years.
Twenty percent were active duty (n=10), 8% active duty dependent (n=4), 40% retiree (n=20),
and 30% retiree dependent (n=15). There was one individual whose beneficiary category was
deceased family member and was categorized as other.
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BMI. Obesity is defined as Grade I (BMI >30 – 34.9 kg/m2), Grade II (BMI >35 – 39.9
kg/m2), and Grade III (BMI >40 kg/m2). The average BMI for the records reviewed was 33.08
kg/m2, with a range of 30.18 to 55.65. Sixty-four percent of individuals’ BMI fell between 30
and 34.9 kg/m2 (n=32), 20% between 35 and 39.9 mg/m2 (n=10), and 16% at 40 mg/m2 and
above (n=8). Distribution of BMI by gender, age, and beneficiary category are noted in Table 1.
Table 1
Individual Visit Variables

Age

Beneficiary Category

Grade I
BMI 3034.99 kg/m2

Grade II
BMI 3539.99 kg/m2

Grade III
BMI 40
kg/m2 and
above

Gender
Male

Female

Total

20-29

AD (2)

2

0

0

30-39

AD (4)

3

1

0

40-49

AD (2)
Retiree (6)

2
5

0
1

0
0

50-59

AD (1)
Retiree (8)

1
5

0
2

0
1

60+

Retiree (4)

1

1

2

20-29

AD Dependent (1)

1

0

0

30-39

AD Dependent (1)

0

0

1

40-49

AD Dependent (2)
Retiree Dependent (3)

1
2

0
1

1
0

50-59

AD Dependent (1)
Retiree (1)
Retiree Dependent (8)

0
1
4

1
0
2

0
0
2

60+

Retiree (1)
Retiree Dependent (4)
Other (1)

1
2
0

0
0
1

0
2
0

50

31

10

9
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PCPs. A total of 119 records were reviewed between 1 April to 31 August 2016 at an
AF MTF located in Maryland until 50 records were identified that met project eligibility criteria.
At the time of data collection, there were a total of seven family physicians, six PAs, and one
NP. Of the data collected from the resultant 50 records, 52% (n=26) of patients were cared for
by family physicians and 48% (n=24) were cared for by PAs and NPs. Individuals were seen for
annual or wellness visits 20% of the time (n=10), acute issues 56% of the time (n=28), and for
chronic issues 24% of the time (n=12). Of note, family physicians cared for more chronic issues
while PA/NPs cared for more physical or wellness exams (Table 2). The frequency of
identification and diagnosis by provider type was similar for both family physician and PA/NPs
(Table 3).
Table 2
Provider Type and Reason for Individual Visit
Reason for Visit
Provider Type

Physical

Acute Issue

Chronic Issue

Total

Family Physician

3

14

9

26

PA/NPs

7

14

3

24

10

28

12

50

Total
Table 3

Provider Type and Obesity Identification/Diagnosis
Obesity Identification/Diagnosis
Provider Type

Yes

No

Total

Family Physician

8

18

26

PA/NPs

10

14

24

18

32

50

Total
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Obesity Treatment Composite Score. The PCPs diagnosed obesity for 36% of visits
(n=18). Of the 18 individuals identified and diagnosed with obesity, 100% received both dietary
and exercise counsel, 44% (n=8) received or were offered behavioral counseling, and 33% (n=6)
received a one-month follow-up appointment. When considering the entire sample, only 36% of
individuals were offered diet and exercise counsel, 16% were offered behavioral counsel, and
12% were offered or received a one-month follow-up appointment. The majority of the followup appointments were with the Disease Manager, as these individuals were identified with
comorbid conditions such as diabetes or hypertension; however, one individual had a stand-alone
diagnosis of morbid obesity when seen for follow-up evaluation.
Of the 50 records reviewed, only 40 individuals were eligible for pharmacologic
management due to AF guidance on use of medication therapy in the AD population.

Obesity Treatment Indicator Results
36

% Accomplished

36

36

16
12
0

0

Obesity Treatment Components
Obesity ID/Diagnosed

Diet Counsel Offered

Exercise Counsel Offered

Behavior Counsel Offered

1 Mo Follow-up Appt

Pharmacologic Option Offered

Surgical Option Offered

Figure 2. Obesity Treatment Indicator Results indicate individuals received obesity treatment
according to the VA/DoD guideline less than 50% of the time.
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Of those 40 individuals, there was no recommendation for pharmacologic management. Based
on TRICARE eligibility requirements for surgical management, 14 individuals were eligible to
receive this recommended option. No eligible individuals were provided this recommended
option for obesity management. It should be noted that one individual had received bariatric
surgery and was categorized as not applicable. Another individual had received a bariatric
surgery consult more than two years prior, but this was not readdressed at the visit and was
categorized as not being offered surgical intervention. See Figure 2 depicting the obesity
treatment indicator results.

Obesity Treatment Composite Score

PCPs Obesity Treatment Composite Score
> 1.00

1

0.75-0.99

2

0.50-0.74

12

0.25-0.49

3

0.00-0.24

32
0

5

10

15

20

25

30

35

Frequency

Figure 3. PCPs Obesity Treatment Composite Score indicates the majority of individuals
received one indicator or less for their obesity identification and treatment.
The Obesity Treatment Composite Score averaged 0.22, ranging from 0.00 to 1.00.
When categories were grouped, 56% (n=28) scored 0.00, 8% (n=4) ranged from 0.01 to 0.24,
10% (n=3) ranged from 0.25 to 0.49, 24% (n=12) ranged from 0.50 to 0.74, 2% (n=2) ranged
from 0.75 to 0.99, and 2% (n=1) met 100% of the interventions recommended by the VA/DoD
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guideline (see Figure 3 for PCP Obesity Treatment Composite Score results). The average
composite score was 0.22 and 0.23 for physicians and PA/NPs respectively.
Discussion
The purpose of this research utilization project was to determine if military PCPs are
identifying and treating obesity in adults in the primary care setting according to the VA/DoD
adult obesity guideline. Obesity has been associated with several cardiovascular, metabolic, and
functional issues such as T2DM, dyslipidemia, osteoarthritis, and depression (Bray, Look, &
Ryan, 2013; Rueda-Clausen et al., 2015). In the military population, obesity affects recruitment
and the readiness mission (Stefan, 2016). In one cohort study of military members who were
followed for a period of 36 years beginning at age 22, it was found that males with early
adulthood obesity were at increased risk for developing ischemic heart disease and congestive
heart failure (Schmidt, Bøtker, Pedersen, & Sørensen, 2014). However, effects of obesity can be
mitigated with a small amount of weight loss, accomplished with just a brief mention of obesity
and treatment advice at a primary care visit (Aveyard et al., 2016).
Identification/Diagnosis of Obesity. Primary care providers are well-positioned to
discuss weight management with patients, because they are the individual’s first-line assessment
(Asselin, Osunlana, Ogunleye, Sharma, & Campbell-Scherer, 2015). Yet findings from this
research utilization project indicate PCPs identify and diagnose obesity only 36% of the time.
This result is better than or comparable to other studies demonstrating rates ranging from 23.8%
to 42% (Farran, Ellis, & Barron, 2013; Fitzpatrick & Stevens, 2017; Klabunde et al., 2014;
Petrin, Kahan, Turner, Gallagher, & Dietz, 2016). Records evaluated from one study required
hand calculation of the BMI. Interestingly, of those that met obesity criteria, less than 1% were
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identified and diagnosed; however, 12 records included an obesity diagnosis but had no recorded
BMI (Barnes, Theeke, & Mallow, 2015).
It was not determined in this research utilization project whether PCPs understood the
definition of obesity, but in a study by Meadows and Weiss (2015), 86% of the providers were
able to correctly define overweight and obesity. An interesting finding, though, was that only
37% of the nonprovider staff were able to correctly define overweight and obesity. In a military
Family Practice Clinic setting, increased reliance on medical support staff is made when taking
an accurate medical history. When medical support staff bring clinical problems to the attention
of the PCP, there is greater opportunity for an issue such as obesity to be addressed when both
parties are knowledgeable.
Diet, Exercise, and Behavioral Counsel. For individuals in this research utilization
project whose obesity was identified and diagnosed during a visit, 100% of them were provided
diet and exercise counsel. However, of the total obese individuals studied, only 36% were
offered information on diet and exercise, and 16% were offered behavioral counseling. This
suggests diet, exercise, and behavior modification counsel were only offered if the diagnosis of
obesity was made, and not as a routine part of healthy lifestyle advice. No records noted advice
given for commercial weight loss programs or meal replacement regimens (Tsai et al., 2016).
This could be a reflection that TRICARE does not provide coverage for such programs.
Findings from this research utilization project were similar to a study conducted by
Magee, Everts, and Jamison (2012). The authors found PCP advice on weight loss interventions
occurred 34.4% of the time, but the study did not specify which interventions were offered
(Magee et al., 2012). Farran et al. (2013) reported a much lower intervention rate for diet,
exercise, and behavior modification counsel at 8.6%, 4.8%, and 1% respectively. Although
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Magee et al. (2012) found a significant difference between interventions offered by physicians
and NPs (x2[1, n=180] = 56.69, p < 0.001), little difference in obesity practice between
physicians (0.22 average composite score) and PA/NPs (0.23 average composite score) were
noted in this research utilization project.
Pharmacotherapy. The VA/DoD obesity guideline (2014) recommends adjunct
treatment with pharmacotherapeutics for individuals who are obese, those whose BMI is > 27
kg/m2 with comorbid conditions. There were no individuals in this research utilization project
who were offered adjunct medication therapy. Six of the medications currently approved by the
Federal Drug Administration are phentermine, orlistat, lorcaserin, naltrexone-bupropion,
phentermine-topiramate, and liraglutide (Apovian et al., 2015). A systematic review and metaanalysis for five of these medications demonstrated at least a 5% weight loss that was sustained
across nearly an entire year (Khera et al., 2016). Despite demonstrated efficacy, under
TRICARE guidelines weight loss medications are not a formulary item (TRICARE, 2016b). A
PCP may write a prescription to be filled at a local network pharmacy, but the individual would
be responsible to cover the cost of the prescription.
Irrespective of systematic barriers, other strategies can be considered to achieve options
for pharmacologic treatment (Tsai et al., 2016). Phentermine is a relatively inexpensive
medication, and many individuals who have no contraindications may desire this as an adjunct
therapy. Orlistat has a preparation that is an over-the-counter product that can be suggested as an
option for the individual. A final strategy is for the PCP to place a nonformulary request with
justification for the medication. If approved, this could provide the individual with adjunct
therapy. Developing regional expertise and educating PCPs can enhance utilization of
medication therapy (Tsai et al., 2016).
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Bariatric Surgery. Bariatric surgery is recommended for individuals who are morbidly
obese, or individuals whose BMI is > 35 kg/m2 with comorbid obesity conditions and who have
attempted to lose weight without improvement (VA/DoD, 2014). It is reported nationally the
prevalence rate for morbid obesity is 6.4%, yet the rate of bariatric surgery is only 1.5% for those
qualified to receive this treatment option (Idzik & Davenport, 2011; Petrin et al., 2016). For this
research utilization project, there were no PCPs who recommended bariatric surgery as a
treatment option. As observed with pharmacologic therapy, one might initially speculate that
this treatment option is not a covered TRICARE benefit. However, TRICARE does cover
bariatric surgery (TRICARE, 2016a) per the VA/DoD guideline recommendations (VA/DoD,
2014), thus consideration should be made regarding PCP education and attitude toward obesity
treatment to assist in designing interventions to improve the identification/diagnosis and
treatment of obesity in military primary care settings (Salinas, Glauser, Williamson, Rao, &
Abdolrasulnia, 2011).
Implications/Sustainability/Need for Future Evidence-Based Projects
Use of an obesity guideline assists PCPs in the identification and effective treatment of
obesity in the primary care setting (Kushner & Ryan, 2014). In this project, identification and
treatment of obesity occurred 22% of the time. This reflects that translating the guideline into
clinical practice is challenging. The Diffusion of Innovations Theory addresses four elements by
which the VA/DoD obesity guideline could be diffused into the military social system, including
aspects of the innovation itself, communication, adoption process, and influence of the social
system.
Areas that may have limited the use of the VA/DoD obesity guideline are lack of
familiarity or provider agreement, patient receptivity and stigma, patient compliance with
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change, and system or organizational constraints can influence use of guidelines (Abruzzino &
Marra, 2015; Gunther, Guo, Sinfield, Rogers, & Baker, 2012; Idzik & Davenport, 2011; Monsen
et al., 2014; Sadeghi-Bazargani et al., 2014; Sinfield et al., 2013).
A PCPs decision to accept or reject use of the guideline is dependent on their knowledge
and attitude toward the guideline. Studies show education and peer reviews alone may produce
variable outcomes in adherence to use of a guideline (Idzik & Davenport, 2011; Monsen et al.,
2014). However, education and training, in conjunction with tools such as outreach, reminders,
and sustained support, be implemented to improve providers’ adherence to guidelines (Farran et
al., 2013; Idzik & Davenport, 2011; Monsen et al., 2014). Additionally, a PCP's skill influence
the offering of weight loss advice to patients (Dutton et al., 2014; Farran et al., 2013). Brief
training on motivational interviewing and use of the 5As approach can offer PCPs additional
tools that build skill and confidence to counsel obese patients on guideline recommendations
(Edwards, Stapleton, Williams, & Ball, 2015; Gudzune, Clark, Appel, & Bennett, 2012; Vallis et
al., 2013).
Finally, guidelines that are easy to follow with limited organizational constraints can
enhance utilization (Gunther et al., 2012; Klabunde et al., 2014). Implementation of enhanced
collaborative and consultative mechanisms can increase the provider’s confidence to refer
individuals for additional care and shifts sole responsibility from the PCP to a coordinated
organizational response (Gunther et al., 2012; Monsen et al., 2014).
Further evaluation needs to be conducted to identify the barriers unique to this MTF.
Without understanding the barriers, it can make targeting effective interventions difficult. By
focusing future evidence-based projects on these areas, it may enhance the diffusion of the
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obesity guideline into practice and ultimately reduce the consequences of obesity for this
population.
Limitations
This research utilization project has several identified limitations. The small number of
records audited may limit providing an accurate clinical picture of obesity management. It could
be possible that the identification/diagnosis and treatment of adult individuals in this sample setting
was actually higher or lower than reported. The need for sampling a larger number of records is
indicated. Additionally, there are approximately 75 MTFs in the AF Medical Service. Findings
from this population may not be reflective of practices at other DoD medical facilities. However,
the data collected, although random, were somewhat systematic to ensure audits were conducted
throughout each month of the data collection period, as well as to ensure each PCP was audited
equally to avoid targeting only one or two. Further, more explicit details of the intervention were
not addressed in this research utilization project. If dietary counsel was documented, this was
counted as an intervention. However, it was not specific to whether the PCP offered calorie
information, use of food logs, use of commercial products, or other dietary counsel. It is possible
one dietary intervention may offer greater benefit than another.
A historical bias that may have influenced project outcomes is that this particular MTF site
is one of the locations staffed with a research division that spawned research related to diabetes and
obesity under the Diabetes and Obesity Research Working Group established in 2010 (True,
Cranston, & Hatzfeld, 2013). It is possible project outcomes may have been influenced by some of
the working group’s activities.
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Dissemination of Future Scholarly Activity and Results
Following defense of this research utilization project, it is anticipated that the findings
will be formally presented to the MTF’s executive leadership as well as to the Population Health
Working Group. Locally, results will be forwarded to the MTF’s EBP and Quality Councils.
Future evidence-based interventions are being planned to improve PCPs’ adherence to guidelines
for the identification and treatment of obesity. Following additional planned interventions, the
principal investigator (PI) anticipates seeking publication of the findings in the peer-reviewed
journal, Military Medicine. If program interventions are successful, this author plans to
collaborate with the Diabetes and Obesity Research Working Group to advance policy at AF and
possibly DoD levels to improve obesity rates for TRICARE beneficiaries. Finally, this author
plans to request for either podium or poster presentation at the American Association of Nurse
Practitioners National Conference in 2018 and other appropriate professional presentation
opportunities that impact cardiometabolic health.
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Appendix A
Obesity Assessment Tools: Advantages and Disadvantages
Assessment Tool

Advantage

Disadvantage

BMI

Easy, inexpensive; estimates
abdominal subcutaneous fat

Lean body mass can lead to
elevated measurement; does not
account for non-European stature;
less predictive for central obesity

WC

Easy, inexpensive; predictive of
central obesity; race specific

Reduced reproducibility

WHR

Predictive of central obesity

Reduced reproducibility

WSR

Easy, inexpensive; good for nonobese; race specific

Reduced reproducibility

Skinfold
thickness

Inexpensive

MRI

Accurate

Timely; requires training;
variability; reliability low in
severely obese; not reliable for
central obesity
Expensive; time consuming

CT

Accurate

Expensive; exposure to radiation;
time consuming

Ultrasound

Accurate to measure
subcutaneous fat

Expensive; less accurate with skin
compression and fat plasticity

DEXA

Expensive; time consuming

Air Densitometry

Accurate; safe except in
pregnancy; can assess central
obesity
Accurate; no water immersion

Hydrodensitometry

Very accurate

Expensive; time consuming; must
be underwater to measure; poor
determinant of body composition

Bioelectrical
Impedance

Fast, easy

Not accurate; dependent on
hydration status; equipment cost

Expensive; cannot determine body
composition

Sources: Adapted from Müller et al., 2013; Rueda-Clausen et al., 2015
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Appendix B
AGREE II Appraisal of Obesity Guidelines
AGREE II Rating
Domain

Item

1. The overall objective(s) of the guideline is (are) specifically
described.
2. The health question(s) covered by the guideline is (are specifically
Scope and described).
Purpose
3. The population (patients, public, etc.) to whom the guideline is
meant to apply is specifically described.
Total (21)
4. The guideline development group includes individuals from all
the relevant professional groups.
Stakeholder 5. The views and preferences of the target population (patients,
Involvement public, etc.) have been sought.
6. The target users of the guideline are clearly defined.
Total (21)
7. Systematic methods were used to search for evidence.
8. The criteria for selecting the evidence are clearly described.
9. The strengths and limitations of the body of evidence are clearly
described.
10. The methods for formulating the recommendations are clearly
described.
11. The health benefits, side effects and risks have been considered
Rigor of
Development in formulating the recommendations.
12. There is an explicit link between the recommendations and the
supporting evidence.
13. The guideline has been externally reviewed by experts prior to
its publication.
14. A procedure for updating the guideline is provided.
Total (56)
15. The recommendations are specific and unambiguous.
16. The different options for management of the condition or health
Clarity of issue are clearly presented.
Presentation
17. Key recommendations are easily identifiable.
Total (21)
18. The guideline describes facilitators and barriers to its
application.
19. The guideline provides advice and/or tools on how the
recommendations can be put into practice.
Applicability 20. The potential resource implications of applying the
recommendations have been considered.
21. The guideline presents monitoring and/or auditing criteria.
Total (28)
22. The views of the funding body have not influenced the content of
the guideline.
Editorial
23. Competing interests of guideline development group members
Independence
have been recorded and addressed.
Total (14)

Total Composite Score (161)
Overall
Guideline
Assessment

1. Rate the overall quality of this guidance.
2. I would recommend this guideline for use (please respond: yes,
yes with modifications, or no).
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Endocrine
Society

VA/DoD

AHA/ACC/
TOS

USPTF

6

7

7

5

1

7

7

7

5
12

6
20

6
20

6
18

4

6

6

4

2
7
13
7
6

2
7
15
7
7

2
7
15
7
7

2
7
18
7
6

6

6

6

6

5

6

6

5

6

6

6

6

5

6

6

5

5
4
44
6

5
7
50
6

7
6
51
6

6
6
47
5

6
7
19

7
7
20

7
7
20

5
5
15

3

4

3

6

4

4

4

6

1
4
12

1
4
13

1
4
12

1
4
17

7

3

7

7

7
14

1
4

7
14

1
8

95

102

112

108

4

5

6

5

Y

Y w/mod

Y w/mod

Y w/mod

Appendix C
Obesity Guideline Recommendations

Recommendation

Endocrine
Society

Clinic Assessment Not applicable

VA/DoD

AHA/ACC/
TOS

USPTF

BMI

BMI, WC

BMI

Diet

Counsel BMI
>25

Counsel all
Varietyb

CLIf as
indicated x 6
month

CLI for
BMI >25

Exercise

Counsel BMI
>25

Counsel all
Varietyc

High-intensity
>14 sessions x 6 CLI for BMI
month
>25

MId

May use
commercial
product

CLI for BMI
>25
Balance
risk/benefit

Behavioral
Counsel

Counsel BMI
>25

Pharmacologic
Options

Meds at BMI
>27 wca, >30

Meds at BMI
>27 wca, >30

Not available at
time of
publication

Surgical Options

BMI >35 wca,
>40

BMI >35 wca,
>40

BMI >40

Not reviewed

Follow-up

Every 1 month,
then every 3
months, stop if
no change

Annual; CLIe
every month
for 12 months

Face-to-face or
telephone
support

No evidence to
support
frequency of
screening; CLI
12-26
sessions/yr

Shared decisionmaking

Yes

Yes

Not discussed

Not discussed

Sources: Apovian et al., 2015; Jensen et al., 2013; Moyer, 2012; VA/DoD, 2014.
a

wc = with comorbidity (i.e. T2DM, HTN, dyslipidemia, OSA); blow carb, low fat, DASH
diet, low calorie, meal replacement; c10 minute short burst to longer continuous; dMI =
motivational interview; eComprehensive Lifestyle (diet, exercise, behavioral counsel)
Intervention w/moderate activity 150-300 minutes/week; fCLI w/high-intensity activity
200-300 minutes/week, include smoking cessation counsel
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Appendix D
Pharmacologic Agents for Treatment of Obesity
Medication
Orlistat OTCa

Activity
Lipase inhibitor

Recommended Dose
60 mg 3 times daily

Orlistat
(prescription)

Lipase inhibitor

120 mg 3 times
daily

Phentermine

Sympathomimetic
agent

15 mg daily,
increase as indicated
30 mg daily
37.5 mg (resin)
75 mg daily max

Inexpensive
Weight loss 3-5%

Phentermine/
topiramatec
extended
release

Sympathomimetic
agent/carbonic
anhydrase
inhibitor

Weight loss >5%

Lorcaserinc

Serotonin 5HT-2C
receptor agonist

3.75 mg/23 mg daily
for 2 weeks, then
increase as tolerated
7.5 mg/46 mg daily
11.25 mg/69 mg
daily
15 mg/92 mg daily
10 mg 2 times daily

Naltrexone/
Bupropion

μ-opioid
antagonist/
dopamine &
noradrenaline
reuptake inhibitor
Glucagon-like
peptide-1 agonist

8 mg/90 mg 1 tablet
for 1-2 weeks, then
2 tablets for 3-4
weeks, then 2 tablets
2 times daily
0.6 mg daily,
increase to max 3
mg subcutaneous
daily

Weight loss >5%
Treatment for food
addiction

Liraglutide

Benefits
Weight loss 2-3%
Decrease in LDL-Cb
Good safety profile
Non-systemic
Inexpensive
See above

Weight loss
Improved Hgb A1Cd
Tolerability good

Risks
Gastrointestinal (GI)
upset: Oily stools,
bowel urgency

See above
More expensive than
Orlistat OTC
Elevated heart
rate/palpitations/
blood pressure,
insomnia
GI upset
Caution in use with
CV disease
Expensive
Same as
Phentermine
Altered taste
Paresthesia
Depression/anxiety
Teratogenic
Expensive
May experience
headache, nausea,
dry mouth,
constipation
Risk of serotonin
syndrome w/ other
serotonergic meds
Mid-range cost
Headache,
nausea/vomiting,
dizziness

Expensive
Injection
Thyroid medullary
cancer
Nausea/vomiting
Pancreatitis
Sources: Adapted from Apovian et al., 2015; Chugh & Sharma, 2012; McKinney, 2013; Ryan, 2014.
a

Weight loss

OTC = over-the-counter; bLDL-C = low density lipoprotein cholesterol; cDiscontinue if ineffective after
12 weeks; dHgb A1C = glycated hemoglobin
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Appendix E
Detailed Research Utilization Project Timeline
Task Date(s)

Category/Objective

Task

4 Jan – 11 Apr 2016

Proposal Defense

Draft Chapter 1 – Introduction
Draft Chapter 2 – Literature Review
Draft Chapter 3 – Theoretical Underpinnings
Draft Chapter 4 – Project Plan
Committee Approval
Proposal Defense Presentation

1 Jun - 22 Sep 2016

IRB Approval

Submit IRB application with requested
modification to UNLV IRB

6 - 30 Sep 2016

Update Chapter Drafts

Update Chapter 1 - Introduction

1 - 31 Oct 2016

Update Chapter Drafts

Update Chapter 2 – Literature Review

20 - 24 Oct 2016

IRB/AF Research Oversight
and Compliance Division
Approval

Submit UNLV IRB approval letter with
requested modification to AF Research
Oversight and Compliance Division

1 Nov - 30 Nov 2016

Update Chapter Drafts

Update Chapter 3 – Theoretical
Underpinnings

1 Dec - 17 Dec 2016

Update Chapter Drafts

Update Chapter 4 – Project Plan

1 Dec - 23 Dec 2016

AF Research Oversight and
Compliance Division Approval

Coordinate with MTF Clinical Research
Office and AF Research Oversight and
Compliance Division for final approval to
conduct research utilization project

9 Jan - 29 Jan 2017

Data analysis

Analyze demographic and audit data

30 Jan - 3 Apr 2017

Research Project Defense

Draft Chapter 5 – Results
Committee Approval
Project Defense Presentation

4 Apr - 21 Apr 2017

Research Project
Dissemination

Finalize edits
Prepare presentation for MTF Executive
Staff
Prepare research project for dissemination to
Military Medicine journal
Initiate expansion of research utilization
project to improve AF obesity rates
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Appendix F
University of Nevada – Las Vegas Institutional Review Board and
AF Research Oversight and Compliance Division Approval Letters
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46
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Appendix G
Obesity Treatment Audit Form
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